SAIPARENT Share Price Today - Sai Parenteral's on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,935.50	#1 4,64,391.28	40.42	#1 61,673.90	12.69	#1 11,565	25.80	70.46
Divis Laboratories	6,836.00	1,81,474.32	70.42	10,560.00	8.73	2,520	13.44	56.74
Torrent Pharmaceuticals	4,901.50	1,65,889.03	77.50	13,886.20	20.34	2,138	-26.91	75.89
Cipla	1,439.40	1,16,281.25	30.16	29,044.60	2.24	3,870	-55.32	56.94
Zydus Life Science	1,150.80	1,15,797.41	22.58	26,719.70	13.65	5,242	7.82	69.26
Lupin	2,496.30	1,14,138.96	#1 21.37	27,487.50	19.98	5,345	#1 87.72	70.07
Mankind Pharma	2,525.10	1,04,285.61	53.94	14,277.60	12.03	1,750	31.75	59.01
Dr Reddys Laboratories	1,244.30	1,03,857.87	25.49	35,058.60	3.90	4,158	-86.05	39.41
Aurobindo Pharma	1,564.70	90,029.38	26.31	33,384.70	3.21	3,376	1.99	61.30
Laurus Labs	1,537.80	83,019.15	91.21	6,867.80	#1 22.01	890	21.18	61.14

Quarterly Financials	Dec 2025	Mar 2026
Revenue	99	201
Expenses	100	172
EBITDA	-0	29
Operating Profit %	-4 %	13 %
Depreciation	6	8
Interest	5	8
Profit Before Tax	-12	12
Tax	-5	-1
Net Profit	-7	13
EPS in ₹	-2.22	4.02

Balance Sheet	2023	2024	2025	2026
Total Assets	134	268	272	1,424
Fixed Assets	45	70	53	451
Current Assets	82	187	200	822
Capital Work in Progress	2	0	1	212
Investments	0	0	0	172
Other Assets	88	198	219	0
Total Equity & Liabilities	134	268	272	1,424
Current Liabilities	77	153	162	573
Non Current Liabilities	26	39	14	357
Total Equity	32	76	96	491
Reserve & Surplus	24	61	80	469
Share Capital	7	13	13	22

Cash Flow	2023	2024	2025
Net Cash Flow	-8	3	-2
Investing Activities	-19	-46	0
Operating Activities	-13	-30	33
Financing Activities	24	79	-36

% Holding	Sept 2025	Mar 2026	Apr 2026
Promoter	61.23 %	51.16 %	51.16 %
FIIs	0.00 %	5.73 %	5.73 %
DIIs	0.00 %	12.86 %	12.86 %
Government	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	22.67 %	22.67 %
Others	38.77 %	7.59 %	7.59 %
No of Share Holders	119	143	7,687

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
23 May 2026	Quarterly Result Announcement	NA	23 May 2026	478.60	486.70

Funding House	Current Holding %	1M Change	1M Change %	3M Change %	Last 6M Trend
Quant Momentum Fund Direct-Growth	0.92%	0	0.00%	-2.09%
Quant Small Cap Fund Direct Plan-Growth	0.00%	0	0.00%	-0.05%

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Sai Parenteral's

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Quarterly Financial Results

Balance Sheet

Cash Flow

Share Holding

Corporate Action

Announcements

Mutual Fund Holdings

Technical Indicators